73462-101 : Cosela 300 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: | 73462-101 |
Labeler: | G1 Therapeutics, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Cosela |
Dosage Form: | Intravenous Injection, Powder, Lyophilized, for Solution |
Application #: | NDA214200 |
Rev. Date: |
NDC Package Codes:
- 73462-101-01: 1 VIAL, GLASS IN 1 CARTON (73462‑101‑01) > 20 ML IN 1 VIAL, GLASS
Active Ingredients:
- Trilaciclib Dihydrochloride
Dosage Strength:
- 300 mg/20mL
Pharmaceutical Classes:
- Cyclin-dependent Kinase 4 Inhibitors [MoA]
- Cyclin-dependent Kinase 6 Inhibitors [MoA]
- Kinase Inhibitor [EPC]
- Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]
- Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]
- Organic Cation Transporter 2 Inhibitors [MoA]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 73457-415Next: 73464-001 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.